Over the weekend, I pulled up the 10-Q financial notes and dissected the entire earnings call transcript line by line.

My honest takeaway?

Management’s report card barely squeezed by with a passing grade. While we got preliminary answers to the three core questions I laid out earlier, a hidden red flag also popped up on the balance sheet.

Here is my raw, unfiltered breakdown as a professional accountant who looks at financial ledgers for a living.

1. Checking the Answers to My 3 Core Questions

• Question 1: What was the real nature of those “Commercial Actions”?

  • Management’s line: They claimed this was simply a rebate adjustment for previously sold high-priced inventory, promising it “would not impact future cash obligations.”

  • My accountant take: I hunted through the accounting notes in the 10-Q, and frankly, the underlying accounting logic remains murky. My professional instinct tells me management is playing word games with the phrase “no cash impact.” If this was merely a structural rebate tweak, it shouldn’t hit the income statement at all. My trust in management just took another notch down.

• Question 2: What is the 2027–2028 guidance for the new patented pipeline?

  • The projected trajectory for 2027 and 2028 actually looks pretty strong. This was one of the few genuine bright spots in the entire release.

• Question 3: How fast can they trim operational costs?

  • The cost-cutting effects are slated to kick in by the second half of 2027. It’s middle-of-the-road—neither a big surprise nor a total disappointment.

2. The Hidden Minefield: An $800 Million DTA Valuation Allowance

Beyond my initial questions, the 10-Q revealed a detail that makes any financial manager hyper-vigilant: FMC took a massive $800 Million valuation allowance against its Deferred Tax Assets (DTA).

In plain English: The company is officially admitting they might not generate enough future taxable profit to actually use that $800M in tax credits, so they wiped it off the asset side of the balance sheet.

While multinational tax structures are complex and a DTA write-down doesn’t automatically mean core operations are dead, it sends a different picture than the one paitned by management’s rosy talk of a “strong 2027–2028 recovery.” Not a good signal.

So, why am I not dumping the stock after all these mixed signals?

Because of the sheer, absurd margin of safety in the current valuation. Even after Friday’s impressive 30% rally, the market cap sits around $1 Billion.

Look at the conservative math based on their 2028 guidance:

• 2028 Projected EBITDA: ~$800 Million.

• Subtract interest expenses, depreciation, and taxes...

• Bottom-line Net Income (Floor): You’re still conservatively looking at ~$300 Million in net profit.

Do the math: a $1B valuation on $300M in net earnings translates to a dirt-cheap 3x Forward P/E ratio. That valuation floor is simply too low to ignore.

Taking all these facts together, my action plan is crystal clear: I will NOT add a single new share, but I will NOT sell a single share either. I am holding my position firmly right where it is.

The CEO of FMC actually said something during the call that nailed it on the head:

“We clearly recognize that the only way to rebuild investor trust in FMC is to deliver results and prove it through execution.”

Exactly. Since management knows that painting rosy pictures doesn’t work anymore, it’s time to shut up and let the financial statements do the talking.

Friday’s 30% rebound was a nice start.

Disclosure: I hold a long position in FMC Corp (NYSE: FMC) at the time of writing. As a value investor, I run a concentrated portfolio and manage my own risk. However, I may buy, sell, or adjust my holdings at any time without prior notice.

Disclaimer: This article represents my personal investment journal and is for informational and educational purposes only. It is NOT financial or investment advice. I am a professional accountant sharing my own research, not your financial advisor. Always do your own homework before investing.

I sat down, read through every detail, and did the math. Here is my raw, unfiltered bottom line:

1. Is the company going bankrupt in the short term? No. Liquidity is fine, and cash flow will get them through the winter.

2. Is the recovery timeline delayed? Absolutely.

3. What changed? The $1 Billion they raised to pay off high-interest debt just got effectively halved by these commercial write-downs/adjustments. That means interest costs will stay higher for longer, eating into net profits.

My initial recovery estimate of 3 to 5 years has now been pushed back to 4 to 6 years (or even 7 years).

I am holding my position for now, but I am not buying another dime until management answers three crucial questions on October 29th.

Let’s tear open the engine bay and look at what’s actually happening under the hood.

1. Short-term Liquidity vs. The Interest Trap

The good news first: FMC will survive this cash crunch.

• They have $400M in fresh external investor cash coming in for Q3.

• They have additional cash injections hitting the balance sheet in Q4 from selling their India business unit and a real estate asset.

The bad news? They raised $1B earlier to pay off expensive, high-interest loans. But with this massive Q3 guidance cut and commercial revenue adjustment, nearly half of that $1B debt relief gets wiped out by operational shortfall.

High interest expenses will continue to sit on the P&L like a heavy rock. Before FMC can show fat bottom-line profits to shareholders, any future cash generated MUST go toward paying off debt first. That pushes the whole profit release schedule out by a couple of years.

2. The Commercial Action Dilemma: Inventory vs. Generic Competition

Management called this guidance drop “commercial actions” (adjusting prices/rebates and channel inventory). This is where the whole thesis hinges:

• Scenario A (Less Terrible): Are these price cuts applied to old, expensive legacy inventory sitting in distribution channels? If so, it’s a one-off reset. Once costs normalize next year, margins recover.

• Scenario B (Nightmare Scenario): Are they forced to permanently lower prices on brand-new, current products? If yes, it means generic competition from low-cost Asian producers is far worse than management led us to believe. Short-term profits will get obliterated until FMC can cut their manufacturing cost structure to match.

3. Management Credibility Takes a Hit

As a finance manager, this frustrates me to no end. FMC is a B2B agricultural chemicals business. How on earth is your channel visibility so poor that you revise Q3 guidance so drastically at the very last minute?

I’m taking everything management says right now with a massive pinch of salt. Their visibility and channel control are under serious scrutiny.

Wall Street loves binary thinking: either a stock is a tech darling going to the moon, or it’s a broken company headed for zero.

Value investing in turnarounds is about gray areas.

FMC’s core long-term moat isn’t their old expired products—it’s their brand-new, patented R&D pipeline coming out over the next few years. That mid-to-long term thesis hasn’t changed. Farmers globally still need crop protection, and FMC’s next-gen products will eventually ramp up.

The market is treating FMC as if it’s going out of business tomorrow. But in reality, this isn’t a funeral; it’s just a much longer stay in the waiting room.

Look, nobody likes seeing a stock in their portfolio drop on bad news. It sucks.

But panicking or revenge-trading is how retail investors blow up their accounts. I’m taking a calm, disciplined approach: I stand still and wait for facts.

I am holding my shares, watching three specific items during the October 29th earnings release and October 30th conference call:

1. Clarification on Commercial Actions: Is this a one-time inventory reset, or a structural price collapse against generic competition?

2. 2027 & 2028 Guidance: What does the new trajectory look like for the new patented pipeline?

3. Cost Optimization Plan: How fast can they trim operational fat to protect margins?

If the core thesis holds and bankruptcy risk remains near zero, I will let time do the heavy lifting. But I am keeping my eyes wide open.

Disclosure: I hold a long position in FMC Corp (NYSE: FMC) at the time of writing. As a value investor, I run a concentrated portfolio and manage my own risk. However, I may buy, sell, or adjust my positions at any time without prior notice.

Disclaimer: This article represents my personal investment journal and is for informational and educational purposes only. It is NOT financial or investment advice. I am a professional accountant sharing my own research, not your financial advisor. Always do your own due diligence before investing.

Here is the quick breakdown of my Q3 2026 performance:

• My Q3 Portfolio Return: +8.11%

• S&P 500: +2.03%

• Nasdaq: +2.47%

TL;DR: Got lucky this quarter

Here is every move I made and how my individual holdings performed between July 1st and September 30th:

• Sold Danaos (DAC): Locked in a ~23% gain and rotated that capital straight into SK Hynix (000660.KS). SK Hynix is currently up about 15% in my portfolio.

• Sold Assured Guaranty (AGO): Exited with a modest ~5% gain in Q3 and rotated into FMC Corp (FMC). FMC is currently sitting at an unrealized loss of roughly -23%.

• Held Zhihu (ZH) & Everest Group (EG): Didn’t touch these two during the quarter. Zhihu was up about 14% for Q3, and Everest was up around 3%.

Same old rules: Extreme concentration, 4 stocks max, 100% invested.

Here is the strategic thesis behind my current 4-stock portfolio and what I plan to do next:
1. FMC Corp (NYSE: FMC) — The Turnaround Play

This is a classic long-term turnaround story. Survival is no longer an issue after their $1B balance sheet cleanup, but ramping up their new R&D pipeline will take time. I am fully prepared to sit on my hands and hold this for 3 to 5 years.

2. SK Hynix (000660.KS) — The Safe Value Gateway to AI

Compared to other AI hype stocks flying in outer space at nosebleed valuations, SK Hynix is a grounded value play. I’m prepared to hold this for the ultra long haul.

From my own personal experience and direct conversations with C-suite executives at Fortune 500 companies, the impact of AI is real. Every major department across every industry is either already implementing AI or actively racing to embrace it. I’ll put it out there: This is officially the Third Industrial Revolution. SK Hynix owns the HBM bottleneck, and I’m happy to hold the keys.

3. Zhihu (NYSE: ZH) — On the Chopping Block (With 3 Caveats)

I might exit this position in the short term. My original thesis was that their massive Chinese language dataset would be hugely valuable to AI companies—similar to how Reddit charges tech giants a annual fee with near-zero marginal cost. But the domestic environmentis tough; most big tech companies are essentially free-riding their content.

Why haven’t I pulled the trigger to sell yet? Three reasons:

1. Regulatory & API Monetization: I want to give it a bit more time to see if domestic AI regulations solidify and whether Zhihu can finish building its commercial AI data API interfaces.

2. The Short-Drama Boom in China: Zhihu has tapped right into the massive short-drama trend and is now a top IP supplier in this space. I want to monitor if this growth holds up next quarter.

3. Aggressive Buybacks: Management is putting their money where their mouth is, buying back roughly $200,000 worth of shares every single day.

4. Everest Group (NYSE: EG) — The Anchor of My Portfolio

This reinsurance giant is my portfolio’s main stabilizer. While my other holdings might swing wildly, Everest is my rock. The upside potential might be capped compared to tech, but I am more than happy with it.

With management ditching loss-making insurance lines and their core reinsurance business back on track, it’s essentially a quiet compounding machine. I comfortably see a long-term compound return of 10% to 15% per year here.

Let’s be completely upfront.

Everest Group (NYSE: EG) is the textbook definition of a boring stock. It’s a classic insurance and reinsurance giant. There is no high-tech AI narrative, no 50% revenue growth, and zero chance of it doubling overnight.

If you’re looking for fast excitement, skip this post.

But if you want to know how a conservative value investor makes steady, stupidly reliable money, it comes down to one core concept: Using other people’s money to work for me.

Here are the 3 exact reasons why Everest Group is a money-making machine for its shareholders at today’s price.

Here is the straightforward accounting logic of why the math stacked in our favor is almost unfair:

1. The Magic of Float: Turning a 4.5% Yield into an 18% Return on Equity

Insurance is the ultimate financial model because you collect premiums today and pay out claims years later. That pool of free cash sitting in the middle is called the Float.

Here is the simple balance sheet arithmetic:

• For every $1 of equity owned by shareholders, Everest controls roughly $4 of float.

• With interest rates staying higher for longer, Everest invests that $4 into safe fixed-income assets earning around 4.5%.

• The Math:

• 18% return on your original $1 of equity!

They are literally using low-cost leverage from other people’s cash to generate an 18% ROE engine before even counting their main insurance profit.

2. Core Underwriting is Back on Track (The Combined Ratio Secret)

Of course, float leverage only works if the core insurance business isn’t bleeding money.

In insurance, we track a key metric called the Combined Ratio:

• In plain English: It measures how much money the company pays out in claims and expenses for every dollar of premium collected. A ratio over 100% means they are losing money on underwriting.

• EG’s Combined Ratio has improved back to the low 90s%.

That means for every $100 in premium they take in, they keep roughly $8 to $9 as pure underwriting profit before earning a single dime on their investment portfolio. The core business is profitable, healthy, and cash-generative again.

3. Buying Back $1 of Assets for 90 Cents

Because Wall Street considers insurance “boring” and gets skittish over short-term storm headlines, the stock currently trades below its actual Net Asset Value (Book Value).

Management isn’t sitting idle—they are aggressively buying back their own shares.

• Every single time EG repurchases shares below book value, they are buying $1.00 worth of net hard assets for 90 cents.

• This shrinking share count automatically boosts the intrinsic value and earnings power of every remaining share we hold.

Wall Street analysts often ignore stocks like this because they can’t sell a fancy futuristic story to retail investors. There are no flashy press releases or speculative hype cycles.

But this “boring” reality is our ultimate moat.

While the market runs around chasing overvalued high-beta stocks, Everest Group quietly collects premiums, invests billions of float at high yields, and devours its own discounted shares month after month.

It’s the financial equivalent of a quiet snowball rolling down a long, icy hill. You don’t need magic; you just need compound interest and patience.

I don’t invest to get an adrenaline rush. I invest so I can sleep like a baby every single night.

Everest Group won’t make you the center of attention at a party, and it won’t give you bragging rights on social media. But it gives you real assets, real cash flow, a high margin of safety, and a management team that knows how to allocate capital.

It’s boring. It’s quiet. But it makes money, and most importantly, it lets me sleep in peace.

Disclosure: I hold a long position in Everest Group (NYSE: EG) at the time of writing. As a value investor, I run a concentrated portfolio and put my own money where my analysis leads. However, I may buy, sell, or adjust my holdings at any time without prior notice.

Disclaimer: This article represents my personal investment journal and is for informational and educational purposes only. It is NOT financial or investment advice. I am a professional accountant sharing my own research, not your financial advisor. Always do your own homework before investing.

People always assume value investors only buy cheap, boring, traditional sector stocks—like brick-and-mortar stores or old industrial plays. That’s not true of me.

I look at tech stocks all the time. My rule as an accountant is simple: Every single stock, regardless of its industry, has a price where it makes total sense to buy. Tech is no different.

I’m not blind. I know AI isn’t just hype—it’s a massive wave on par with the Industrial Revolution, and I certainly don’t want to miss out on it. But with the AI craze pushing most US tech stock prices straight to the moon, finding a real bargain feels almost impossible.

I dug deep until I found one that actually fits my strict valuation standards: SK Hynix (listed in South Korea as 000660.KS, NASDAQ ADR Ticker SKHY).

Why buy the primary Korean listing instead of US ADRs? Simple math: The underlying business is identical, the dividend is identical, and the liquidity on the Korean exchange is sky-high. If I can buy the exact same company at a massive discount, why on earth would I pay a premium just because it’s wrapped in a US ticker?

(The US ADR is an alternative only as a last resort for those who physically can’t access foreign markets—and even then, it’s still considerably cheaper than almost any other AI stock out there).

Here is how I am riding the AI train without overpaying for a ticket.

To get why SK Hynix is a rare bargain in today’s tech world, you don’t need a computer science degree. You just need to understand one physical bottleneck in AI servers.

1. What the heck is HBM, and why do AI chips need it?

An Nvidia GPU is like a Bugatti engine. But if you try to feed fuel to that massive engine through a tiny thin drinking straw, the car goes nowhere.

That “drinking straw” problem in AI servers is solved by HBM (High Bandwidth Memory). It’s basically memory chips stacked vertically like a skyscraper. Without HBM, an Nvidia GPU is literally useless.

And guess who is the undisputed king of HBM right now? SK Hynix.

They mastered the manufacturing trick (MR-MUF technology) way before Samsung or Micron. Because of that, they locked up the lion’s share of HBM supply for Nvidia’s flagship GPUs.

2. Why this isn’t your grandfather’s memory stock

Historically, memory makers were treated like cheap commodity sellers with wild price swings. But HBM changes the underlying accounting:

• Custom-made, fat profit margins: HBM isn’t something you buy off a shelf. It’s custom-designed, locked in with long-term contracts, and sells at high profit margins.

• Sucking up factory capacity: Making HBM takes 3 times more factory capacity than regular RAM. This eats up global memory supply, forcing prices of regular computer memory up across the board!

3. Balance sheet cleanup

Did they carry heavy debt during the last memory slump? Yep. But now? HBM is printing cash for them. They are generating massive cash flow and using it to wipe out debt fast—meaning zero risk of shareholder dilution.

Think about it this way.

During a gold rush, hundreds of thousands of people rush into the mountains trying to hit the jackpot. Most of them go home completely broke. But you know who gets rich every single time? The guy selling the shovels and picks to the miners.

Right now, tech giants (Microsoft, Meta, Google, Amazon) are spending hundreds of billions in a crazy AI arms race.

I don’t care which tech giant wins the AI war. Because no matter who wins, EVERY SINGLE ONE OF THEM has to buy tons of HBM memory from SK Hynix.

Because it’s primarily listed in South Korea, Wall Street constantly ignores it due to the “Korea Discount.” While tourists are paying top dollar for overhyped US AI names, SK Hynix is sitting right there at a price that gives us a true margin of safety.

I don’t hate tech stocks, and I don’t hate growth. I just hate overpaying for a dream that might collapse when market sentiment shifts tomorrow.

Buying SK Hynix isn’t gambling on a promise. It’s owning a real, cash-generating industrial monster that controls the biggest hardware bottleneck on the planet—and buying it at a valuation where I can sleep peacefully at night.

That’s how I participate in the AI revolution: with my eyes wide open, my valuation intact, and my margin of safety firmly locked in.

Disclosure: I hold a long position in SK Hynix (000660.KS) at the time of writing. As a value investor, I run a concentrated portfolio and put my own money where my analysis leads. However, I may buy, sell, or adjust my holdings at any time without prior notice.

Disclaimer: This article represents my personal investment journal and is for informational and educational purposes only. It is NOT financial or investment advice. I am a professional accountant sharing my own research, not your financial advisor. Always do your own homework before investing.

Some companies aim to grow profits by maybe 10% a year. Others are literally fighting just to stay alive. If you want massive, life-changing money, you look at the second group—the ones that almost died, but survived, and where getting back to their glory days is just a matter of time.Among the stocks on my radar, I spotted a classic example: FMC Corp (NYSE: FMC). They are the 5th biggest agricultural sciences player globally (right behind giant names like Syngenta, Bayer, BASF, and Corteva). The stock got completely hammered—down over 90% from its peak of around $120+. But here’s the cool math: To give us a 5-bagger (5x return), it doesn’t even need to touch its historical peak again. Recovering just half of where it used to be is enough.Here’s why everybody dumped it, why it won’t go bankrupt, and why hedge funds can only watch from the sidelines while we eat the profits.

To see why this is a massive bargain, you first have to look at why this stock was left for dead in the first place.

1. Why survival became a real nightmare

FMC used to own a patented blockbuster insecticide. It had zero close competitors, and they just sat there making insane amounts of money. But then, the patents started expiring country by country.

The cash cow ran dry. Overall earnings went from solid profits into ugly losses. But the real killer wasn’t just the P&L—it was the debt. They had huge high-interest loans hanging over their head, interest had to be paid every month, and cash flow (the absolute bloodline of any business) completely dried up. People panicked, thought they were going under, and the stock crashed 90%.

2. Why bankruptcy is officially off the table

A cash crunch kills a company before it can turn around. But just in the past quarter, FMC pulled off a masterclass move to save their own ass: they scrambled up $1 Billion to pay off their high-interest loans.

How on earth did they get that $1 Billion?

• They sold off their lousy, low-margin business units.

• They licensed out some non-exclusive rights.

• They brought in a big external investor who literally pumped in fresh cash—at a share price HIGHER than today’s market price.

Think about how sweet that is: we get to buy the exact same company today at a lower price than a billionaire investor who just threw $400 million into it!

3. Why returning to glory is just a matter of time

Surviving is great, but how do they actually make money again?

FMC isn’t just relying on old expired stuff. Besides their legacy products that still sell really well because farmers around the world trust their brand name, they have a monster R&D pipeline coming out.

In fact, they already launched a brand-new patented product line—and one of them is the first of its kind in human history with zero substitutes! As these new patented products ramp up over the coming years, they will easily make up for the money lost from the old ones.

Now, you’re probably asking: “If FMC is such a clear no-brainer, why aren’t all the smart-guy hedge funds on Wall Street buying it right now?”

Because Wall Street managers have a dirty little secret: They have zero patience.

Ramping up newly patented agricultural products takes time—conservatively speaking, 3 to 5 years to get global farmers to adopt them.

Hedge funds and big fund managers get judged on their performance EVERY SINGLE QUARTER. If a fund manager buys FMC today and the stock just sits there sideways for a year while waiting for sales to ramp up, their clients will throw a tantrum and withdraw their money.

They physically CANNOT buy this potential 5-bagger, even if they KNOW it’s going back up, because they can’t afford to wait 3 to 5 years!

Their stupidity is our opportunity. As independent value investors, we don’t have clients breathing down our necks. We can just buy, sit back, and wait.

Look, I know buying a stock that dropped 90% sounds terrifying. Nobody likes catching a falling knife.

But I’m not playing flip-a-coin day trading anymore. I like deals where the worst-case scenario is already taken care of by a clean balance sheet, and the best-case scenario is backed by real, patented products that farmers actually need to feed the world.

FMC isn’t some shady crypto coin or tech startup that might disappear tomorrow. It’s a solid, real-world business, and the worst of their money problems is officially behind them.

Now, all we need to do is sit on our hands and let time do the heavy lifting!

___________________________________________

Disclosure: I hold a long position in FMC Corp at the time of writing. I run a highly concentrated portfolio, so when I like a business, I put my own money where my mouth is. However, I may buy, sell, or adjust my position at any time without prior notice.

Disclaimer: This post represents my personal investment journal and is for informational and educational purposes only. It is NOT financial, investment, or legal advice. I am sharing my own research as a professional accountant, not acting as your financial advisor. Investing in stocks involves significant risk, including the loss of principal. Always do your own due diligence or talk to a licensed financial advisor before putting your hard-earned money to work.

I am a professional accountant, a history buff, and I’ve been burning my fingers in the stock and forex markets for over a decade. After trying almost every strategy out there, I finally stripped everything down to the essentials. My portfolio is highly concentrated. I own a maximum of 4 stocks at any single point in time. Period.

This Substack is just my public diary. I’m going to document exactly how I continue to snowball my wealth over the coming years. If you want to see how a professional accountant filters out the noise and makes high-conviction bets, welcome aboard.

Before settling on value investing, I spent years trying to beat the market through forex and stock day trading. I didn’t quit those markets because I lost interest; I quit because the math just didn’t make sense.

Here is exactly why I walked away:

1. Why I quit Forex (The Leverage Trap): Leverage sounds amazing until it acts against you just once. If it does, your entire portfolio is gone. That’s exactly what happened to me back in 2015 when the Swiss National Bank unexpectedly removed the CHF exchange rate floor. In a matter of minutes, a single black swan wiped me out completely. I realized I’m not playing a game where one unpredictable event can reset my life savings to zero.

2. Why I quit Day Trading (The Asymmetric Loss): Day trading stocks drained my energy, and more importantly, my capital. Two things broke me:

   • The Fees: Transaction fees add up to a very material amount over time. When you calculate the drag, you realize you’re playing a rigged coin-flip. It’s a game where if it’s heads, you win $1, but if it’s tails, you lose $2 after accounting for fees. The asymmetry is completely stacked against you.

   • The Madness: Daily price moves are almost purely based on speculative buys and sells. It’s noise. I decided I am absolutely not going to bet my hard-earned money on how crazy people decide to behave on any given day.

So, why value investing? Because after looking at thousands of financial statements, I concluded this is the absolute safest way to build sustainable wealth.

I don’t use leverage, and I don’t count on how foolish other people are to make money. Instead, I look at stocks as real businesses. If I can buy an incredible business with a massive margin of safety—ideally trading way below its intrinsic value—I dont’ give a shit what the broader market does tomorrow.

Running a 4-stock portfolio means I have to say “no” to almost everything. But when you find something truly asymmetric, you don’t diversify, you concentrate.

Look, I know how stressful investing can be. The anxiety of watching tickers all day, the fear of getting margin called, and the frustration of realizing your profits were eaten up by your broker—I’ve been there, and I’ve paid my tuition fees to the market.

I chose value investing not just for the returns, but for peace of mind. I want to build wealth safely and deliberately.

In this space, I am going to share my actual framework, my thought process, and even my mistakes. No filters, no institutional jargon. Just real numbers and real thinking.

My next post will be about how I actually screen thousands of global stocks down to a maximum of 4 high-conviction names.

If you’re tired of the noise and want to see how the compounding journey actually works, hit subscribe.